공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 합법적 마리화나 시장

Legal Marijuana

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997495
페이지 정보 영문 146 Pages
가격
US $ 4,950 ₩ 5,582,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 16,747,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 합법적 마리화나 시장 Legal Marijuana
발행일 : 2021년 04월 페이지 정보 : 영문 146 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 합법적 마리화나 시장 규모는 분석기간(2020-2027년)에 20.9%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 242억 달러에서 2027년에는 912억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 의료용 대마는 분석기간 중 20.6%의 CAGR을 나타내고, 690억 달러에 달할 전망입니다.

세계의 합법적 마리화나(Legal Marijuana) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • Aphria Inc.
  • Aurora Cannabis, Inc.
  • Beacon Medical
  • Canopy Growth Corporation
  • Cronos Group
  • OrganiGram Holdings, Inc.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • Wayland Group Corporation

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 세계 시장 궤적
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 46개사
LSH 21.04.08

Abstract:

Global Legal Marijuana Market to Reach $91.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Legal Marijuana estimated at US$24.2 Billion in the year 2020, is projected to reach a revised size of US$91.2 Billion by 2027, growing at aCAGR of 20.9% over the period 2020-2027. Medical Marijuana, one of the segments analyzed in the report, is projected to record 20.6% CAGR and reach US$69 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Recreational Marijuana segment is readjusted to a revised 21.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 20.1% CAGR

The Legal Marijuana market in the U.S. is estimated at US$7.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.6 Billion by the year 2027 trailing a CAGR of 20.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.7% and 18.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.4% CAGR.

Select Competitors (Total 46 Featured) -

  • Aphria Inc.
  • Aurora Cannabis, Inc.
  • Beacon Medical
  • Canopy Growth Corporation
  • Cronos Group
  • OrganiGram Holdings, Inc.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • Wayland Group Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Legal Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Medical Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Recreational Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Recreational Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Mental Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 15: USA Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 16: USA 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 17: USA Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 18: USA 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • CANADA
    • TABLE 19: Canada Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Canada 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 21: Canada Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 22: Canada 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • JAPAN
    • TABLE 23: Japan Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 24: Japan 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 25: Japan Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Japan 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • CHINA
    • TABLE 27: China Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 28: China 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 29: China Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 30: China 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • EUROPE
    • TABLE 31: Europe Current & Future Analysis for Legal Marijuana by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 33: Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 34: Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 35: Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • FRANCE
    • TABLE 37: France Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: France 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 39: France Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: France 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • GERMANY
    • TABLE 41: Germany Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Germany 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 43: Germany Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Germany 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • ITALY
    • TABLE 45: Italy Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: Italy 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 47: Italy Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Italy 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 49: UK Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: UK 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 51: UK Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: UK 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Rest of Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 55: Rest of Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Rest of Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 57: Asia-Pacific Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Asia-Pacific 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 59: Asia-Pacific Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Asia-Pacific 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 61: Rest of World Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Rest of World 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 63: Rest of World Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Rest of World 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46
Back to Top
전화 문의
F A Q